Bioxytran (BIXT) Assets (QoQ) (2011 - 2026)
Bioxytran (BIXT) Assets (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.57% |
| Dec 31, 2025 | 321.35% |
| Sep 30, 2025 | 5.96% |
| Jun 30, 2025 | 8.42% |
| Mar 31, 2025 | -1.90% |
| Dec 31, 2024 | -12.78% |
| Sep 30, 2024 | 23.69% |
| Jun 30, 2024 | 2.40% |
| Mar 31, 2024 | -9.93% |
| Dec 31, 2023 | -26.27% |
| Sep 30, 2023 | 32.14% |
| Jun 30, 2023 | -38.74% |
| Mar 31, 2023 | -37.04% |
| Dec 31, 2022 | -17.30% |
| Sep 30, 2022 | -21.06% |
| Jun 30, 2022 | -29.67% |
| Mar 31, 2022 | 577.28% |
| Dec 31, 2021 | -84.35% |
| Sep 30, 2021 | -15.89% |
| Jun 30, 2021 | 135.22% |